NCT02964078 2026-04-02
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Toulouse
Chinese University of Hong Kong
University of Colorado, Denver
Brigham and Women's Hospital